Anti-Breast Cancer Compound Library - 50 μL

- A unique collection of 2440 compounds with anti-breast cancer therapeutic activity or targeting breast cancer’s major signaling pathways, can be used for anti-breast cancer drug discovery and mechanism study； - Targets include HER-2, VEGF, EGFR, PARP, CDK4/6, HSP, PD-1, SET7/9, BRCA, etc.； - Some compounds have been in market or in clinical trials; - Detailed compound information with structure, target, and biological activity description； - NMR and HPLC validated to ensure high purity and quality.